Skip to main content
Menu
US

AlphaLISA AAV1 Detection Kit, 500 Assay Points

The AlphaLISA™ immunoassay kit for AAV1 enables the quantitative determination of AAV1 capsids in buffer, cell culture media, cell lysates and cell supernatants using a homogeneous AlphaLISA assay (no wash steps).

For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).

Feature Specification
Application Bioprocessing
Dynamic Range 7.6E+06 - 1.0E+11 VP/mL
Limit of Detection 7.6E+06 VP/mL
Limit of Quantification 2.6E+06 VP/mL
Sample Volume 10 µL

The AlphaLISA™ immunoassay kit for AAV1 enables the quantitative determination of AAV1 capsids in buffer, cell culture media, cell lysates and cell supernatants using a homogeneous AlphaLISA assay (no wash steps).

For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).

Product Variants
Unit Size: 100 Assay Points
Part #:
AL3181HV
List Price
USD 1,460.00
Unit Size: 500 Assay Points
Part #:
AL3181C
List Price
USD 5,244.00
Unit Size: 5,000 Assay Points
Part #:
AL3181F
List Price
USD 48,570.00

Overview

Adeno-associated virus (AA) vectors are the leading platform for gene delivery for the treatment of a variety of human diseases. AAV Serotype 1 is an efficient vector for gene delivery to skeletal muscle or the central nervous system. The AAV1 kit is designed to detect and quantify AAV1 particles.

Formats
  • Our 100 assay point kit allows you to run 100 wells in 96-well format, using a 50 µL reaction volume (10 µL of sample).
  • Our 500 assay point kit allows you to run 500 wells in 96-well or 384-well format, using a 50 µL reaction volume (10 µL of sample).
  • Our 5,000 assay point kit allows you to run 5,000 wells in 96-well or 384-well format, using a 50 µL reaction volume (10 µL of sample).
Features
  • No-wash steps, no separation steps
  • ELISA alternative technology
  • Sensitive detection
  • Broad sample compatibility
  • Small sample volume
  • Results in less than 3 hours
  • Half the time of an ELISA assay

AlphaLISA technology allows the detection of molecules of interest in a no-wash, highly sensitive, quantitative assay. In an AlphaLISA assay, a biotinylated anti-analyte antibody binds to the Streptavidin-coated Donor beads while another anti-analyte antibody is captured by AlphaLISA Acceptor beads. In the presence of the analyte, the beads come into close proximity. The excitation of the Donor beads causes the release of singlet oxygen molecules that triggers a cascade of energy transfer in the Acceptor beads, resulting in a sharp peak of light emission at 615 nm.

Specifications

Application
Bioprocessing
Automation Compatible
Yes
Brand
AlphaLISA
Detection Modality
Alpha
Dynamic Range
7.6E+06 - 1.0E+11 VP/mL
Limit of Detection
7.6E+06 VP/mL
Limit of Quantification
2.6E+06 VP/mL
Product Group
Kit
Sample Volume
10 µL
Shipping Conditions
Shipped in Blue Ice
Target
AAV1
Target Class
Viral Particles
Technology
Alpha
Unit Size
500 Assay Points

Image gallery

Video gallery

Resources

Are you looking for resources, click on the resource type to explore further.

1-3 of 3 Resources
Whitepaper Icon
Whitepaper
Adeno-Associated Virus (AAV) Vectors Manufacturing

What Are the Challenges and Solutions?

All across the globe, AAVs are getting the attention of scientists and companies working in...

Whitepaper Icon
Whitepaper
Complete gene therapy review in a single industry report

With the increased understanding of molecular and cellular medicine, more specific and efficient gene transfer vectors are now...

Whitepaper Icon
Whitepaper
Shifting the treatment paradigm: the promise of gene therapy for neurodegenerative diseases

Neurodegenerative diseases, such as Alzheimer’s, Parkinson’s, and Huntington’s, are complex disorders that affect millions...

Scroll Icon